Zacks Research Issues Negative Forecast for MRK Earnings
Merck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Merck & Co., Inc. in a report released on Tuesday, April 1st. Zacks Research analyst S. Ganoria now expects that the company will post earnings of $2.34 per share for the quarter, […]
